NeuroMetrix (NASDAQ: NURO) is a medical device company that develops and markets products for the detection, diagnosis and monitoring of peripheral nerve and spinal cord disorders and other chronic diseases. The company develops wearable medical technology and point-of-care tests that help patients and physicians manage chronic pain, nerve diseases and sleep disorders. Its products include Quell, a wearable device for relief of chronic pain; and the SENSUS pain therapy device, a prescription neuro-stimulation device based on transcutaneous electrical nerve stimulation for relief of chronic, intractable pain. For more information, visit the company’s website at www.neurometrix.com.
About NetworkNewsWire
NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information, visit https://www.networknewswire.com
Please see full disclaimers on the NetworkNewsWire website: http://nnw.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.networknewswire.com
212.418.1217 Office
Editor@NetworkNewsWire.net
